POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50 Lowering Capacity

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

The design and preparation of highly efficient drug delivery platforms using green methodologies is at the forefront of nanotherapeutics research. POxylated polyurea dendrimers are efficiently synthesized using a supercritical-assisted polymerization in carbon dioxide. These fluorescent, pH-responsive and water-soluble core-shell smart nanocarriers show low toxicity in terms of cell viability and absence of glutathione depletion, two of the major side effect limitations of current vectors. The materials are also found to act as good transfection agents, through a mechanism involving an endosomal pathway, being able to reduce 100-fold the IC50 of paclitaxel.

Original languageEnglish
Pages (from-to)1045-1051
Number of pages7
JournalMacromolecular Bioscience
Volume15
Issue number8
DOIs
Publication statusPublished - Aug 2015

Keywords

  • oligo-oxazolines
  • paclitaxel
  • polyurea dendrimers
  • POxylation
  • supercritical carbon dioxide
  • DRUG-DELIVERY
  • STRATEGIES
  • CANCER
  • NANOPARTICLES
  • THERAPEUTICS
  • ENDOCYTOSIS
  • MECHANISMS
  • OLIGOMERS
  • DESIGN
  • FUTURE

Fingerprint

Dive into the research topics of 'POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50 Lowering Capacity'. Together they form a unique fingerprint.

Cite this